Feb 10 (Reuters) - Bayer AG BAYGn.DE:
BAYER: APPLIES FOR APPROVAL IN THE EU FOR 6-MONTH TREATMENT INTERVAL WITH EYLEA 8MG
BAYER: APPLICATION BASED ON POSITIVE LONG-TERM RESULTS FROM PULSAR, PHOTON TRIALS OVER THREE YEARS
Source text: [ID:]
Further company coverage: [BAYGn.DE]